TargED Biopharmaceuticals BV raises 39m in Series A financing
TargED Biopharmaceuticals will use 39m from a Series A financing to bring its thrombolytic treatment to patients.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1125 entries already.
Entries by Thomas Gabrielczyk
Finnish VTT spin-out Onego Bio Ltd raises 10m
/in News/by Thomas GabrielczykThe cellular agriculture spin-off Onego Bio Ltd has been seeded with 10m to use its Trichoderma platform to establish an animal-free egg protein production.
Moderna wants to extent its European footprint
/in News/by Thomas GabrielczykThe former mRNA start-up Moderna Inc is set to expand its commercial network in six European nations to become a gobally active vaccine company.
Centauri Therapeutics starting with £24m financing
/in News/by Thomas GabrielczykAntimicrobial resistance specialist Centauri Therapeutics Ltd has closed a £24m Series A round to identify novel therapeutic candidates using the Alphamer technology.
Curve Therapeutics in US$1.7bn deal with MSD
/in News/by Thomas GabrielczykCurve Therapeutics has inked a contract with US pharma giant Merck & Co. (MSD) to screen novel small molecule drug candidates against five MSD targets.
Newton Biocapital launches new NBC III fund
/in News/by Thomas GabrielczykNewton Biocapital has launched a new life sciences fund with initial capital commitments of 50m and a target size of 150m.
New funds to boost European life sciences
/in News/by Thomas GabrielczykEuropean investment firm LSP has closed its European life sciences fund LSP at 1 bn. Additionally, a 10bn fund of funds was greenlighted at the EU Council in Paris.
Aicuris licences antisense RNA know-how from Hybridize Therapeutics
/in News/by Thomas GabrielczykAiCuris will pay up to 100m to Dutch Hybridize Therapeutics BV for the development of antisense RNA therapeutics that stop BK viraemia in renal transplant patients.
BioNTech collaborates with AGC Biologics
/in News/by Thomas GabrielczykAGC Biologics supports BioNTech’s manufacturing of an Omicron-based vaccine with plasmids for in vitro transcription.
EU Council confirms European Scale-up Initiative
/in News/by Thomas GabrielczykEU Members States agreed on Tuesday to launch the pan-European Scale-up Initiative, which is aimed to provide 10bn for late-state tech companies.